Almoxatone

Almoxatone
Systematic (IUPAC) name
(5R)-3-{4-[(3-chlorobenzyl)oxy]phenyl}-5-[(methylamino)methyl]-1,3-oxazolidin-2-one
Clinical data
Legal status
  • Uncontrolled
Identifiers
CAS Number 84145-89-1 N
ATC code none
PubChem CID 172287
ChemSpider 150582 YesY
UNII 85V47MCE4Z YesY
ChEMBL CHEMBL2104006 N
Chemical data
Formula C18H19ClN2O3
Molar mass 346.81 g/mol
 NYesY (what is this?)  (verify)

Almoxatone (MD-780,236) is a selective and reversible inhibitor of MAO-B.[1][2] It was patented as an antidepressant and antiparkinsonian agent but was never marketed.[3]

See also

References

  1. Tipton KF, Fowler CJ, McCrodden JM, Strolin Benedetti M (January 1983). "The enzyme-activated irreversible inhibition of type-B monoamine oxidase by 3-(4-[(3-chlorophenyl)methoxy]phenyl)-5-[(methylamino) methyl]-2-oxazolidinone methanesulphonate (compound MD 780236) and the enzyme-catalysed oxidation of this compound as competing reactions". The Biochemical Journal 209 (1): 235–42. PMC 1154077. PMID 6847610.
  2. Dostert P, Strolin Benedetti M, Guffroy C (March 1983). "Different stereoselective inhibition of monoamine oxidase-B by the R- and S-enantiomers of MD 780236". The Journal of Pharmacy and Pharmacology 35 (3): 161–5. doi:10.1111/j.2042-7158.1983.tb04297.x. PMID 6132973.
  3. David J. Triggle (1996). Dictionary of Pharmacological Agents. Boca Raton: Chapman & Hall/CRC. ISBN 0-412-46630-9.


This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.